Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

This is a concise Python 3 programming tutorial for people who think that reading is boring. I try to show everything with simple code examples; there are no long and complicated explanations with ...

So far, running LLMs has required a large amount of computing resources, mainly GPUs. Running locally, a simple prompt with a typical LLM takes on an average Mac ...